Pelthos Therapeutics PTHS
NYSE PTHS
$20.26 -0.75 (-3.55%)
As of: Oct 1, 2026 · 2:47 PM EDT

Pelthos Therapeutics (PTHS) Preferred Shares (2022 - 2023)

Updated

Pelthos Therapeutics (PTHS) recorded Preferred Shares of $60.00 in Q4 2023, unchanged from $60.00 a year earlier.

Analysis

Pelthos Therapeutics (PTHS) Preferred Shares (2022 - 2023) Analysis & Trends

  • Across earlier years, Preferred Shares came in at $60.00 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Pelthos Therapeutics 79.95 Mn -8.44 Mn 11.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 60.00
Dec 31, 2022 60.00
API Access

Pelthos Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=PTHS&period=max&api_key=YOUR_API_KEY